arry-403
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2009 (NCT00859755)
Timeline
Indications
Mechanism of action
- Hexokinase type IVACTIVATOR
GCK activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- amg 151
- amg 151
- arry-403
- arry-403
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01755442 | Phase 1 | Nov 1, 2012 | Amgen |
| NCT01464437 | Phase 2 | Sep 1, 2011 | Amgen |
| NCT00952198 | Phase 1 | Aug 1, 2009 | Array BioPharma |
| NCT00859755 | Phase 1 | Mar 1, 2009 | Array BioPharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amgen | For profit | 2 | 2 | 2 | 2011 |
| Array BioPharma | For profit | 2 | 2 | 1 | 2009 |
2 organizations
Page 1 / 1